Literature DB >> 10966252

Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.

O Selberg1, H Hecker, M Martin, A Klos, W Bautsch, J Köhl.   

Abstract

OBJECTIVE: To evaluate whether plasma concentrations of procalcitonin (PCT), interleukin-6 (IL-6), protein complement 3a (C3a), leukocyte elastase (elastase), and the C-reactive protein (CRP) determined directly after the clinical onset of sepsis or systemic inflammatory response syndrome (SIRS) discriminate between patients suffering from sepsis or SIRS and predict the outcome of these patients.
DESIGN: Prospective study.
SETTING: Medical intensive care unit at a university hospital. PATIENTS: Twenty-two patients with sepsis and 11 patients with SIRS.
MEASUREMENTS AND MAIN RESULTS: The plasma concentrations of PCT, C3a, and IL-6 obtained < or =8 hrs after clinical onset of sepsis or SIRS but not those of elastase or CRP were significantly higher in septic patients (PCT: median, 16.8 ng/mL, range, 0.9-351.2 ng/mL, p = .003; C3a: median, 807 ng/mL, range, 422-4788 ng/mL, p < .001; IL-6: median, 382 pg/mL, range, 5-1004 pg/mL, p = .009, all Mann-Whitney rank sum test) compared with patients suffering from SIRS (PCT: median, 3.0 ng/mL, range, 0.7-29.5 ng/mL; C3a: median, 409 ng/mL, range, 279566 ng/mL; IL-6: median, 98 pg/mL, range, 23-586 pg/mL). The power of PCT, C3a, and IL-6 to discriminate between septic and SIRS patients was determined in a receiver operating characteristic analysis. C3a was the best variable to differentiate between both populations with a maximal sensitivity of 86% and a specificity of 80%. An even better discrimination (i.e., a maximal sensitivity of 91% and a specificity of 80%) was achieved when PCT and C3a were combined in a "sepsis score." C3a concentrations also helped to predict the outcome of patients. Based on the sepsis score, a logistic regression model was developed that allows a convenient and reliable determination of the probability of an individual patient to suffer from sepsis or SIRS.
CONCLUSIONS: Our data show that the determination of PCT, IL-6, and C3a is more reliable to differentiate between septic and SIRS patients than the variables CRP and elastase, routinely used at the intensive care unit. The determination of PCT and C3a plasma concentrations appears to be helpful for an early assessment of septic and SIRS patients in intensive care.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966252     DOI: 10.1097/00003246-200008000-00019

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  50 in total

Review 1.  Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity.

Authors:  Emanuel P Rivers; Lauralyn McIntyre; David C Morro; Kandis K Rivers
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

Review 2.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 4.  Biomarkers for the differentiation of sepsis and SIRS: the need for the standardisation of diagnostic studies.

Authors:  T C Hall; D K Bilku; D Al-Leswas; C Horst; A R Dennison
Journal:  Ir J Med Sci       Date:  2011-07-30       Impact factor: 1.568

Review 5.  Current Recommendations for the Diagnosis of Acute and Chronic PJI for Hip and Knee-Cell Counts, Alpha-Defensin, Leukocyte Esterase, Next-generation Sequencing.

Authors:  Karan Goswami; Javad Parvizi; P Maxwell Courtney
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

6.  Out-of-hospital characteristics and care of patients with severe sepsis: a cohort study.

Authors:  Christopher W Seymour; Roger A Band; Colin R Cooke; Mark E Mikkelsen; Julie Hylton; Tom D Rea; Christopher H Goss; David F Gaieski
Journal:  J Crit Care       Date:  2010-04-08       Impact factor: 3.425

7.  Circulating inflammatory mediators in patients with fever: predicting bloodstream infection.

Authors:  A B Groeneveld; A W Bossink; G J van Mierlo; C E Hack
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

8.  Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.

Authors:  Sarah E Sartain; Nancy A Turner; Joel L Moake
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

9.  Coagulase-negative Staphylococcus, catheter-related, bloodstream infections and their association with acute phase markers of inflammation in the intensive care unit: An observational study.

Authors:  Oleksa Rewa; John Muscedere; Steve Reynolds; Xuran Jiang; Daren K Heyland
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

10.  Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study.

Authors:  Christopher W Seymour; Sachin Yende; Melanie J Scott; John Pribis; Robert P Mohney; Lauren N Bell; Yi-Fan Chen; Brian S Zuckerbraun; William L Bigbee; Donald M Yealy; Lisa Weissfeld; John A Kellum; Derek C Angus
Journal:  Intensive Care Med       Date:  2013-05-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.